The absence of elevated CA-125 in the context of ER/PR negativity might suggest a less advanced or less biologically aggressive tumor, but clinical correlation, imaging, and pathological assessment are essential for accurate staging and management [28]. The gene discussed is MUC16; the disease is neoplasm.